Crinetics Pharmaceuticals Inc.

This study tested whether a new drug called CRN04894 could safely help adults with congenital adrenal hyperplasia (CAH) better control their hormone levels. Thirty-eight participants took the drug for 12 weeks while researchers checked for side effects and measured key hormones i…

This study tested a drug called paltusotine in people with carcinoid syndrome, a condition caused by certain rare tumors that leads to severe flushing and diarrhea. Thirty-six participants took either a 40 mg or 80 mg dose for 8 weeks, with the option to continue for up to 28 mon…

This completed early-stage study aimed to understand how the body processes a new drug called atumelnant and to check its safety in healthy people. It involved 21 healthy Japanese and Caucasian adults who received either the drug or a placebo. The main goals were to measure drug …